Theriva Biologics's total assets for Q1 2026 were $38.25M, an increase of 0.02% from the previous quarter. TOVX total liabilities were $22.85M for the fiscal quarter, a -0.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.